CAS: 1421830-13-8
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Lulizumab REF: 3D-CLA1361CAS: 1421830-13-8 | - - - | To inquire | Fri 13 Dec 24 |
 | Lulizumab pegol REF: TM-T77074CAS: 1421830-13-8 | - - - | 365.00 €~2,412.00 € | Tue 21 Jan 25 |
Lulizumab pegol
CAS:1421830-13-8
Lulizumab pegol (BMS-931699) is an anti-CD28 antibody, curbing T-cell growth, with potential in kidney transplant …
Color and Shape:
Liquid
Ref: TM-T77074
| 1mg | 365.00 € | ||
| 5mg | 889.00 € | ||
| 10mg | 1,183.00 € | ||
| 25mg | 1,789.00 € | ||
| 50mg | 2,412.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
